407 related articles for article (PubMed ID: 19710368)
1. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
2. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
4. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites.
Sentellas S; Ramos I; Albertí J; Salvà M; Antón F; Miralpeix M; Beleta J; Gavaldà A
Eur J Pharm Sci; 2010 Mar; 39(5):283-90. PubMed ID: 20093184
[TBL] [Abstract][Full Text] [Related]
5. An update on the efficacy and safety of aclidinium bromide in patients with COPD.
Alagha K; Bourdin A; Tummino C; Chanez P
Ther Adv Respir Dis; 2011 Feb; 5(1):19-28. PubMed ID: 20884687
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
[TBL] [Abstract][Full Text] [Related]
7. Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile.
Gavaldà A; Gras J; Llupià J; Aubets J; Beleta J; Llenas J
Life Sci; 2012 Feb; 90(7-8):301-5. PubMed ID: 22213116
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
[TBL] [Abstract][Full Text] [Related]
9. Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
Cazzola M
Curr Opin Investig Drugs; 2009 May; 10(5):482-90. PubMed ID: 19431081
[TBL] [Abstract][Full Text] [Related]
10. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
Rogliani P; Calzetta L; Ora J; Lipsi R; Segreti A; Matera MG; Cazzola M
Eur J Pharmacol; 2015 Aug; 761():383-90. PubMed ID: 25952728
[TBL] [Abstract][Full Text] [Related]
13. Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD.
Vestbo J; Vogelmeier C; Creemers J; Falques M; Ribera A; Gil EG
COPD; 2010 Oct; 7(5):331-6. PubMed ID: 20854047
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants.
Jansat JM; Lamarca R; de Miquel G; Schrödter A; Miletzki B; Gurniak M
J Clin Pharmacol; 2009 Oct; 49(10):1239-46. PubMed ID: 19592595
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonist.
Gupta S; Malhotra S; Sinha S; Singh SK; Singh RK; Krishna S; Chhabra P; Chaira T; Kannayiram J; Sharma P; Aeron S; Kaur J; Kumar N; Sattigeri J; Shirumalla RK; Paliwal J; Dastidar SG; Cliffe IA; Ray A; Bhatnagar P
Eur J Pharmacol; 2011 May; 658(2-3):219-28. PubMed ID: 21371471
[TBL] [Abstract][Full Text] [Related]
16. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
Maltais F; Milot J
Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
[TBL] [Abstract][Full Text] [Related]
17. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Harrison S; Gigli PM; Janni A; Geppetti P; Civelli M; Patacchini R
Br J Pharmacol; 2006 Jun; 148(3):291-8. PubMed ID: 16565730
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the cough reflex by aclidinium and tiotropium in awake and anesthetized rabbits.
Mutolo D; Cinelli E; Iovino L; Pantaleo T; Bongianni F
Pulm Pharmacol Ther; 2016 Jun; 38():1-9. PubMed ID: 27080033
[TBL] [Abstract][Full Text] [Related]
20. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Page CP; Matera MG
Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
